Skip to main content
Premium Trial:

Request an Annual Quote

Coda Closes $7M VC Round, Will Use Cash for Biofuel Initiative and Rx Demo

NEW YORK (GenomeWeb News) — Coda Genomics has pocketed a $7 million Series C round of private equity financing and plans to use the cash to fund and manage growth, particularly in its collaborations with pharmaceutical companies, the company said today.
 
Coda CEO Robert Molinari said the financing will push growth in “several opportunistic areas,” including translational engineering, funding a biofuel enzyme initiative with the University of California, Irvine, and developing a therapeutic candidate demonstration project.
 
Leading the round was OVP Venture Partners, along with current investors Monitor Ventures, Tech Coast Angels, and Life Science Angels.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.